Docetaxel Provectis 160 mg/8 ml, Konzentrat zur Herstellung einer Infusionslösung

7680704270034 CH-70427 Konzentrat

Associated product:

DOCETAXEL Provectis 160 mg/8 ml solution à diluer

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/06/2026
Summary of Product Characteristics
Français
11/06/2026
Summary of Product Characteristics
Italien
11/06/2026

Detailed composition

Substance Quantity Type Category
docetaxelum
160.0 MG Substance Wirkstoff (Principe actif)
docetaxelum trihydricum
- Substance WIZUS
polysorbatum 80
- Substance HNIDK
acidum citricum
- Substance HNIDK
ethanolum anhydricum
3.16 G Substance HBESI

Reimbursement information

Public price
CHF 428.90
Specialties list
Yes
Generic
Yes
SL addition date: 01/07/2026

Authorization holder

PROVECTIS HEALTHCARE AG

4058 Basel

Authorization information

Swissmedic authorization number
70427
Drug name
Docetaxel Provectis, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOKIN
ATC Code
L01CD02
Authorization status
Z
Dispensing category
A
First authorization
12/01/2026
Authorization expiration date
11/01/2031
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
DOCETAXEL Provectis 160 mg/8 ml solution à diluer
Description (DE)
DOCETAXEL Provectis 160 mg/8 ml Konzentrat für ein
Market launch
15/04/2026
Narcotic (BTM)
No

Other package sizes (2)

DOCETAXEL Provectis 20 mg/1 ml solution à diluer p
1 DUR
GTIN: 7680704270010
View
DOCETAXEL Provectis 80 mg/4 ml solution à diluer p
1 DUR
GTIN: 7680704270027
View
Buy us a coffee Explore the data